Learn how radiopharmaceuticals are transforming cancer treatment and creating new opportunities for biotech and pharma ...
The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...
In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...
The National Cancer Center Japan (NCC) has announced the start of a new clinical trial for an anticancer drug prescreened with tumor-bearing mice, saying the use of such mouse models could ...
Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...
This information is based on a press release statement from Celcuity. In other recent news, Celcuity Inc. has announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug ...
Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...
SAN DIEGO - BioAtla, Inc. (NASDAQ:BCAB) announced Wednesday a $40 million special purpose vehicle (SPV) transaction with GATC Health Corp. to advance its cancer drug ozuriftamab vedotin (Oz-V) into ...
TOKYO -- Fujifilm Holdings has joined hands with German drugmaker Bayer to develop an immune-based cancer treatment using induced pluripotent stem cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results